SCHEMBL6178958

SCHEMBL6178958

O=S(=O)(c1ccc(C(F)(F)F)cc1)N1CCCC1c1ccc(F)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 4/20 0.84
PSEN1 P49768 1/20 0.51
PSEN2 P49810 1/20 0.51
APH1B Q8WW43 1/20 0.51
NCSTN Q92542 1/20 0.51
APH1A Q96BI3 1/20 0.51
PSENEN Q9NZ42 1/20 0.51
BRD4 O60885 3/20 0.50
BRD2 P25440 2/20 0.50
NOX4 Q9NPH5 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
GAA P10253 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
LMNA P02545 2/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
BRD3 Q15059 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178961 1.00 TRPA1 (0.84) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6182510 1.00 TRPA1 (0.84) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6182506 1.00 TRPA1 (0.84) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178870 0.92 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178865 0.92 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178585 0.88 PSEN1 (0.67) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178722 0.88 TRPA1 (0.65) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178578 0.88 PSEN1 (0.67) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178726 0.88 TRPA1 (0.65) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177802 0.88 TRPA1 (0.64) TRPA1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP claimed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US claimed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO claimed
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed